Martin Pecherstorfer

Author

Wilhelminen Hospital

Also Known As

M PECHERSTORFER, M Pecherstorfer, M. PECHERSTORFER, M. Pecherstorfer, Martin Pecherstorfer

182

Publications

Citations

H-Index

Concepts

All Affiliations

Wilhelminen Hospital Karl Landsteiner University of Health Sciences Medical University of Vienna Heidelberg University Universitätsklinikum Krems

About

Martin Pecherstorfer is an author at Wilhelminen Hospital specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	30	1.6K
2	Health Sciences	12	12	804
3	Engineering	1	1	20
4	Public Health	1	1	28
5	Cell Biology	1	1	31

Martin Pecherstorfer

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies Jean‐Jacques Body, Ingo Diel, M. Lichinitzer, British Journal of Cancer	2004	334
Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments] Heinz Ludwig, E. Fritz, Clemens Leitgeb, Blood	1994	192
Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer Jean-Jacques Body, Ingo Diel, Richard H. Bell, Pain Cancer QualityPain TherapyPain MedicineOrthopaedic SurgeryOsteoporosis	2004	189
Novel Serum Markers of Bone Resorption: Clinical Assessment and Comparison with Established Urinary Indices Henning W. Woitge, Martin Pecherstorfer, Yuming Li, Journal of Bone and Mineral Research	1999	181
Interleukin-6 and tumor necrosis factor α levels after bisphosphonates treatment in vitro and in patients with malignancy Alain Sauty, Martin Pecherstorfer, Ilse Zimmer-Roth, Bone InflammationTranslational MedicineBisphosphonates TreatmentImmunologyPathology	1996	177
Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin Clemens Leitgeb, Martin Pecherstorfer, E. Fritz, Cancer	1994	169
Prediction of response to erythropoietin treatment in chronic anemia of cancer [see comments] Heinz Ludwig, E. Fritz, Clemens Leitgeb, Blood	1994	129
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy. Martin Pecherstorfer, Z. Herrmann, Jean‐Jacques Body, Journal of Clinical Oncology	1996	127
Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis. IJ Diel, Erich‐Franz Solomayer, Markus J. Seibel, PubMed Breast OncologyPathologyPrimary Breast CancerSerum Bsp ConcentrationsOsteoporosis	1999	118
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings Stefan Kubicka, Richard Greil, Thierry André, Annals of Oncology Gastrointestinal OncologyMedicinePathologyColorectal CancerMetastatic Colorectal Cancer	2013	101

Page 1